- Home
- CODA vs ATRA Comparison
CODA vs ATRA Comparison
Compare CODA & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CODA | ATRA |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.9M | 99.1M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CODA | ATRA |
|---|---|---|
| Price | $9.00 | $17.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 44.1K | ★ 68.4K |
| Earning Date | 01-28-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.09 | N/A |
| EPS | 0.30 | ★ 1.97 |
| Revenue | $24,347,217.00 | ★ $151,930,000.00 |
| Revenue This Year | $30.82 | N/A |
| Revenue Next Year | $20.84 | N/A |
| P/E Ratio | $30.17 | ★ $9.06 |
| Revenue Growth | 29.34 | ★ 51.27 |
| 52 Week Low | $5.76 | $5.01 |
| 52 Week High | $10.54 | $18.71 |
Technical Indicators
Market Signals| Indicator | CODA | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 69.01 |
| Support Level | $8.34 | $14.37 |
| Resistance Level | $9.00 | $15.12 |
| Average True Range (ATR) | 0.40 | 1.15 |
| MACD | 0.08 | 0.44 |
| Stochastic Oscillator | 86.99 | 93.43 |
Price Performance
Historical ComparisonAbout CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).